Treatment of hyperinsulinaemia in polycystic ovary syndrome?
van Montfrans
J M
JM
Research Institute for Endocrinology, Fertility and Metabolism, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
van Hooff
M H
MH
Hompes
P G
PG
Lambalk
C B
CB
D002839:Chromans / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000209:etiology*; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D008687:Metformin; D000077288:Troglitazone; D003981:Diazoxide